Research will explore antibody treatments for EGFR-positive lung cancer, one of the most aggressive and treatment-resistant forms of the disease. NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Israel Cancer ...
Next-generation technologies and diagnostic tests offer the promise of improved cancer care, but they also present challenges related to ensuring widespread access to these innovations. To ensure ...
Public Health Relevance Statement: Idiopathic Pulmonary Fibrosis (IPF) is fatal lung disorder for which no U.S. FDA-approved drugs currently exist. This project will lead to the development of novel ...
UD News University of Dayton researchers are helping Cincinnati Children's Hospital Medical Center by developing artificial ...
4d
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
SAN ANTONIO, October 20, 2025--bioAffinity Technologies will present research related to its noninvasive CyPath Lung test for ...
HONG KONG, Oct. 4, 2025 /PRNewswire/ -- Caretia, a local tech startup based at Hong Kong Science Park, today announced that its AI-powered lung cancer screening platform has achieved initial ...
This project is not being offered for the current term. Please check back next semester for updates. The research of our laboratory is focused on lung embryonic specification and especially lung ...
This project is not being offered for the current term. Please check back next semester for updates. Cancer cells have altered metabolism and consume significantly more glucose than normal cells, a ...
Research will explore antibody treatments for EGFR-positive lung cancer, one of the most aggressive and treatment-resistant forms of the disease. "We are honored to partner with MFCR, a highly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback